IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
- Martine Bagot
- , Pierluigi Porcu
- , Anne Marie-Cardine
- , Maxime Battistella
- , Basem M. William
- , Maarten Vermeer
- , Sean Whittaker
- , Federico Rotolo
- , Caroline Ram-Wolff
- , Michael S. Khodadoust
- , Armand Bensussan
- , Carine Paturel
- , Cecile Bonnafous
- , Helene Sicard
- , Hatem A. Azim
- , Youn H. Kim
Producción científica: Article › revisión exhaustiva
152
Citas
(Scopus)